Evidence map›Paper›PMID 34946696›Full record

ArticleMolecules (Basel, Switzerland)2021

Screening of Promising Chemotherapeutic Candidates from Plants against Human Adult T-Cell Leukemia/Lymphoma (VII): Active Principles from

Daisuke Nakano, Kenji Ishitsuka, Madoka Ishihara, Ryota Tsuchihashi, Masafumi Okawa, Kazuo Tamura, Junei Kinjo

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Molecules (Basel, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.4field-weighted citation impact, top 40% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 6 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Daisuke NakanoFaculty of Pharmaceutical Sciences, Fukuoka University, Fukuoka 814-0180, Japan.
Kenji IshitsukaDivision of Hematology and Rheumatology, Graduate School of Medical and Dental Sciences, Kagoshima University, Kagoshima 890-8544, Japan.
Madoka IshiharaFaculty of Pharmaceutical Sciences, Fukuoka University, Fukuoka 814-0180, Japan.
Ryota TsuchihashiFaculty of Pharmaceutical Sciences, Fukuoka University, Fukuoka 814-0180, Japan.
Masafumi OkawaFaculty of Pharmaceutical Sciences, Fukuoka University, Fukuoka 814-0180, Japan.ORCID 0000-0001-7593-4949
Kazuo TamuraDivision of Medical Oncology, Hematology and Infectious Disease, Department of Internal Medicine, Fukuoka University, Fukuoka 814-0180, Japan.
Junei KinjoFaculty of Pharmaceutical Sciences, Fukuoka University, Fukuoka 814-0180, Japan.
Fukuoka University · JPKagoshima University · JP

Funding

Japan Society for the Promotion of Science JP19K16403
6 · The paper itself

Abstract

During the screening of novel chemotherapeutic candidates from plants against adult T-cell leukemia/lymphoma, we identified that the extracts of

Indexed as

Antineoplastic Agents, PhytogenicCell Line, TumorDrug Screening Assays, AntitumorHumansLeukemia-Lymphoma, Adult T-CellThujaAntineoplastic Agents, Phytogenicadult T-cell leukemia/lymphomascreeningThuja occidentalis

Identifiers

PMID34946696
PMCPMC8707666
OpenAlexW4200511971

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.